Spending Scarce Confirmatory PET Measurements: Target-Aligned Validation in A4/LEARN
arXiv:2608.22223v3 Announce Type: replace-cross Abstract: Anti-amyloid therapies and blood-based biomarkers are changing Alzheimer disease workups into a two-stage measurement workflow: screen broadly with cheaper information, then spend scarce…
Read the full story at arXiv cs.AI ↗
ImpactNotable 31/100
Why it mattersRule-based estimate: event keywords (+4); trust 6/10.
RegionsGlobal
Published8 h ago (Fri, 18 Sep 2026 04:00:00 GMT)
RetrievedFri, 18 Sep 2026 08:00:48 GMT via rss
ClassifiedFri, 18 Sep 2026 08:01:04 GMT by heuristic
AuthorEliuvish Han Cui, Qiang Yang, Meredith Mengmeng Zhang